Background Although mental health concerns are known to occur commonly for those with
inflammatory bowel diseases (IBD), the nature of this comorbid relationship has not been …

Background Tight and personalised control of inflammatory bowel disease in a traditional
setting is challenging because of the disease complexity, high pressure on outpatient clinics …

Background Zinc plays a pivotal role in wound repair, tissue regeneration, and the immune
response. Although zinc deficiency is common in patients with inflammatory bowel disease …

Objectives Previous population-based studies in patients with ulcerative colitis [UC]
revealed variable colectomy rates and colectomy-associated risk factors. Over the past two …

Opinion statement With the expanding armamentarium in IBD the current treatment targets
can be reached. By optimally using our drugs we can avoid long-term complications in IBD …

Background & Aims A subset of patients with inflammatory bowel diseases (IBD) have
continuously active inflammation, leading to a high number of complications and high direct …

Background Real-life data on inflammatory bowel disease (IBD) prevalence and costs are
scarce. The aims of this study were to provide an overview of the prevalence, mortality …

Background Inflammatory bowel disease (IBD) is associated with high costs to society. Few
data on the impact of IBD on work disability and potential predictive factors are available …

Symptomatic ulcerative colitis (UC) can be a chronic, disabling condition. Flares in disease
activity are associated with many of the negative impacts of mild-to-moderate UC. Rapid …

The SIBDCS was launched in November 2006 with the aim of enrolling and following
patients with inflammatory bowel disease (IBD) throughout Switzerland. Our original sample …